161 related articles for article (PubMed ID: 24291945)
1. [Clinical manifestations and epidemiology of prion diseases in Japan].
Hamaguchi T
Rinsho Shinkeigaku; 2013; 23(11):1246-8. PubMed ID: 24291945
[TBL] [Abstract][Full Text] [Related]
2. [Prion disease surveillance in Japan: analysis of 1,241 patients].
Yamada M; Nozaki I; Hamaguchi T; Noguchi-Shinohara M; Kitamoto T; Nakamura Y; Sato T; Mizusawa H
Rinsho Shinkeigaku; 2009 Nov; 49(11):939-42. PubMed ID: 20030254
[TBL] [Abstract][Full Text] [Related]
3. Prospective 10-year surveillance of human prion diseases in Japan.
Nozaki I; Hamaguchi T; Sanjo N; Noguchi-Shinohara M; Sakai K; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Moriwaka F; Shiga Y; Kuroiwa Y; Nishizawa M; Kuzuhara S; Inuzuka T; Takeda M; Kuroda S; Abe K; Murai H; Murayama S; Tateishi J; Takumi I; Shirabe S; Harada M; Sadakane A; Yamada M
Brain; 2010 Oct; 133(10):3043-57. PubMed ID: 20855418
[TBL] [Abstract][Full Text] [Related]
4. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan.
Hamaguchi T; Sakai K; Noguchi-Shinohara M; Nozaki I; Takumi I; Sanjo N; Sadakane A; Nakamura Y; Kitamoto T; Saito N; Mizusawa H; Yamada M
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1171-5. PubMed ID: 23595947
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance of prion diseases in Japan: analysis of 409 patients].
Yamada M
Rinsho Shinkeigaku; 2003 Nov; 43(11):806-9. PubMed ID: 15152470
[TBL] [Abstract][Full Text] [Related]
6. Update: Dura Mater Graft-Associated Creutzfeldt-Jakob Disease - Japan, 1975-2017.
Ae R; Hamaguchi T; Nakamura Y; Yamada M; Tsukamoto T; Mizusawa H; Belay ED; Schonberger LB
MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(9):274-278. PubMed ID: 29518068
[TBL] [Abstract][Full Text] [Related]
7. [Prion diseases in Japan: analysis of 918 patients].
Yamada M
Rinsho Shinkeigaku; 2007 Nov; 47(11):805-8. PubMed ID: 18210803
[TBL] [Abstract][Full Text] [Related]
8. [Prion disease].
Mizusawa H
Rinsho Shinkeigaku; 2010 Nov; 50(11):797-802. PubMed ID: 21921445
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology and surveillance system of prion disease in Japan].
Noguchi-Shinohara M; Hamaguchi T; Yamada M
Nihon Rinsho; 2007 Aug; 65(8):1379-83. PubMed ID: 17695272
[TBL] [Abstract][Full Text] [Related]
10. [Prion disease--the present status and recent progress in Japan].
Mizusawa H
Rinsho Shinkeigaku; 2008 Nov; 48(11):861-5. PubMed ID: 19198101
[TBL] [Abstract][Full Text] [Related]
11. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
[TBL] [Abstract][Full Text] [Related]
12. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
[TBL] [Abstract][Full Text] [Related]
13. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
14. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
[TBL] [Abstract][Full Text] [Related]
15. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
[TBL] [Abstract][Full Text] [Related]
16. [Prion disease--the characteristics and diagnostic points in Japan].
Sanjo N; Mizusawa H
Rinsho Shinkeigaku; 2010 May; 50(5):287-300. PubMed ID: 20535976
[TBL] [Abstract][Full Text] [Related]
17. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
[TBL] [Abstract][Full Text] [Related]
18. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
20. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures.
Hamaguchi T; Noguchi-Shinohara M; Nozaki I; Nakamura Y; Sato T; Kitamoto T; Mizusawa H; Yamada M
Neuropathology; 2009 Oct; 29(5):625-31. PubMed ID: 19659942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
